Acclaimed addiction researcher A. Thomas McLellan has been unanimously confirmed by the U.S. Senate to serve as the deputy director of the White House Office of National Drug Control Policy (ONDCP).
The Philadelphia Inquirer reported Aug. 8 that McLellan’s appointment was approved by unanimous consent.
McLellan, formerly the executive director of the Treatment Research Institute (TRI) at the University of Pennsylvania, will be in charge of demand-reduction policy at ONDCP. “The nation has gained a leader who has been at the forefront of science-based efforts to improve treatment systems for people suffering from drug addictions. We know Tom McLellan will bring this expertise to the country’s efforts to reduce demand for illegal substances of abuse,” said TRI Board Chair Carolyn Asbury, Ph.D.